San Diego, CA – 
MJNA) (the “Company”), the first-ever publicly traded cannabis company in the
United States that launched the world’s first-ever cannabis-derived
nutraceutical products, brands and supply chain, announced today that its
subsidiary Kannaway® has hired Lennon
Ledbetter to become the Company’s Vice President of Sales.
“A company is only as strong as
its executive team and we look forward to strengthening our robust, talented
team with Lennon,” said Kannaway® CEO Blake Schroeder. “Lennon is renowned in
the direct selling industry for being one of the pioneers at the world’s
largest direct selling companies. Since then he has proven himself time and
time again as one of the most influential and successful people in the
industry. He will be tasked with continuing to grow Kannaway’s domestic and
international presence, and with recruiting world-class talent into Kannaway. I
could not be more confident in Lennon’s abilities to take Kannaway to the next
level globally.”
Ledbetter is among the top
achievers in the global direct sales industry and has a strong track record of
generating millions in annual revenue. He is a sought-after motivational
speaker and trainer, speaking to audiences in both packed stadiums and intimate
conferences domestically and internationally. Ledbetter is also well-known for
his mentorship abilities, specifically for inspiring and building successful teams
and creating meaningful professional relationships within high-growth
industries.
“I pride myself on working for
companies that not only care about building successful teams that positively
impact people but also that are looking to innovate and make a difference,”
said Lennon Ledbetter, Kannaway®’s new Vice President of Sales. “Kannaway
checks all these boxes by helping people all over the world gain access to the
highest quality cannabidiol (CBD) products on the market, as well as conveying
the opportunity to thousands to get involved in owning a piece of the growing
cannabis industry. It’s an honor to be invited to join a team that has
pioneered so many things within the cannabis and hemp industries, and one that
aims to continue doing so with its charitable partnerships, international
expansion, and one that is truly focused on building leaders who are inspired
to attain their dreams.”
To learn more about Kannaway®,
please visit https://kannaway.com/.
About Kannaway®
Kannaway® is a network
sales and marketing company specializing in the sales and marketing of
hemp-based botanical products. Kannaway® currently hosts weekly online sales
meetings and conferences across the United States, offering unique insight and
opportunity to sales professionals who are desirous of becoming successful
leaders in the sale and marketing of hemp-based botanical products.
About Medical Marijuana,
Inc.
We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a
cannabis company with three distinct business units in the non-psychoactive
cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands
led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal
non-psychoactive cannabis products derived from industrial hemp; and a
cannabinoid-based clinical research and botanical drug development sector led
by its pharmaceutical investment companies and partners including AXIM®
Biotechnologies, Inc. and Neuropathix. Medical Marijuana, Inc. was named a top CBD
producer by CNBC. Medical Marijuana, Inc. was also the first company to
receive historic import permits for CBD products from the governments of
Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of
international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical
studies throughout Mexico and Brazil to understand its safety and
efficacy.
Medical Marijuana, Inc.’s
headquarters is in San Diego, California, and additional information is
available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s corporate video, click here.
FORWARD-LOOKING DISCLAIMER
This press release may contain
certain forward-looking statements and information, as defined within the
meaning of Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, and is subject to the Safe Harbor created by
those sections. This material contains statements about expected future events
and/or financial results that are forward-looking in nature and subject to risks
and uncertainties. Such forward-looking statements by definition involve risks,
uncertainties and other factors, which may cause the actual results,
performance or achievements of Medical Marijuana, Inc. to be materially
different from the statements made herein.
FOOD AND DRUG ADMINISTRATION
(FDA) DISCLOSURE
These statements have not been
evaluated by the Food and Drug Administration. This product is not intended to
diagnose, treat, cure, or prevent any disease.
LEGAL DISCLOSURE
Medical Marijuana, Inc. does
not sell or distribute any products that are in violation of the United States
Controlled Substances Act.
CONTACT:
Public Relations Contact:
Kathryn Brown
Account Director
CMW Media
P. 858-264-6600
kathryn@cmwmedia.com
www.cmwmedia.com
Investor Relations Contact:
P. (858) 283-4016
investors@medicalmarijuanainc.com